RxDoctor Payments Data

Daniel Charous, MD

Otolaryngology · Goodyear, AZNPI 1326017336

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $181,550 of the $195,801 with a category attached, or 92.7%. Medical Device Business Services, Inc. accounts for 63.9% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $66,634 and has fallen 77.6% since, to $14,901 in 2025. Among otolaryngology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$195,801in general payments, 2019–2025

Across 252 payments — averaging $776.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$125K
  • Aerin Medical Inc.$35K
  • Acclarent, Inc$20K
  • Integra Lifesciences Corporation$14K
  • Intersect ENT, Inc.$977
  • KARL Storz Endoscopy-america$665
  • plus $816 from 9 others
$170,844in research payments, 2019–2025

Across 19 payments — averaging $8991.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$171K

What the payments were for

  • Consulting fees$181,55093%
  • Speaking & faculty fees$3,7962%
  • Travel & lodging$2,1091%
  • Food & beverage$7,6804%
  • Education$6650%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$195,801 in reported general payments places this provider in the 95th percentile of 150 otolaryngology providers in Arizona.

See all otolaryngology providers in Arizona

Medicare billing

Part B allowed, 2024
$558,712
Medicare patients
328
Services billed
2,731

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide98$2,469
Cefdinir16$268
Ofloxacin14$205
Doxycycline Hyclate26$173
Pantoprazole Sodium33$143
Mupirocin20$143
Methylprednisolone22$128

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Goodyear

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →